LT3660073T - Poli(laktidas-ko-glikolidas) su lėtu pradiniu atsipalaidavimu - Google Patents

Poli(laktidas-ko-glikolidas) su lėtu pradiniu atsipalaidavimu

Info

Publication number: LT3660073T
Authority: LT; Lithuania
Prior art keywords: glycolide; lactide; burst; poly; low
Prior art date: 2007-02-15

Application number

LTEP19203071.6T

Other languages

English (en)

Inventor

Eric Dadey

John Middleton

Richard Norton

Original Assignee

Tolmar International Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-15

Filing date

2008-02-13

Publication date

2023-10-10

2008-02-13 Application filed by Tolmar International Limited filed Critical Tolmar International Limited

2023-10-10 Publication of LT3660073T publication Critical patent/LT3660073T/lt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/88—Post-polymerisation treatment
- C08G63/90—Purification; Drying
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Immunology (AREA)
Polymers & Plastics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Neurology (AREA)
Diabetes (AREA)
Virology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Physical Education & Sports Medicine (AREA)
Pregnancy & Childbirth (AREA)

LTEP19203071.6T 2007-02-15 2008-02-13 Poli(laktidas-ko-glikolidas) su lėtu pradiniu atsipalaidavimu LT3660073T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US90143507P	2007-02-15	2007-02-15

Publications (1)

Publication Number	Publication Date
LT3660073T true LT3660073T (lt)	2023-10-10

Family

ID=39504385

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEP19203071.6T LT3660073T (lt)	2007-02-15	2008-02-13	Poli(laktidas-ko-glikolidas) su lėtu pradiniu atsipalaidavimu
LT15185218T LT3202814T (lt)	2007-02-15	2008-02-13	Lėto irimo poli-(laktidas/glikolidas) ir polimerų gamybos būdai

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
LT15185218T LT3202814T (lt)	2007-02-15	2008-02-13	Lėto irimo poli-(laktidas/glikolidas) ir polimerų gamybos būdai

Country Status (16)

Country	Link
US (7)	US9187593B2 (lt)
EP (3)	EP3202814B1 (lt)
JP (3)	JP5342459B2 (lt)
CA (1)	CA2678350C (lt)
CY (2)	CY1116785T1 (lt)
DK (3)	DK3202814T3 (lt)
ES (3)	ES2550014T3 (lt)
FI (1)	FI3660073T3 (lt)
HK (1)	HK1138303A1 (lt)
HR (3)	HRP20231117T3 (lt)
HU (3)	HUE047775T2 (lt)
LT (2)	LT3660073T (lt)
PL (3)	PL3660073T3 (lt)
PT (3)	PT3660073T (lt)
SI (3)	SI3660073T1 (lt)
WO (1)	WO2008100532A1 (lt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8313763B2 (en) *	2004-10-04	2012-11-20	Tolmar Therapeutics, Inc.	Sustained delivery formulations of rapamycin compounds
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
US20070196416A1 (en)	2006-01-18	2007-08-23	Quest Pharmaceutical Services	Pharmaceutical compositions with enhanced stability
PL3660073T3 (pl)	2007-02-15	2023-12-27	Tolmar International Limited	Poli(laktyd-ko-glikolid) o niskim nagłym uwalnianiu
MX354603B (es)	2007-05-25	2018-03-13	Indivior Uk Ltd	Formulaciones de transferencia sostenida de compuestos de risperidona.
AU2009255675B2 (en) *	2008-06-03	2014-10-09	Tolmar Therapeutics, Inc.	Controlled release copolymer formulation with improved release kinetics
US10285936B2 (en)	2010-05-31	2019-05-14	Laboratorios Farmacéuticos Rovi, S.A.	Injectable composition with aromatase inhibitor
US10335366B2 (en)	2010-05-31	2019-07-02	Laboratorios Farmacéuticos Rovi, S.A.	Risperidone or paliperidone implant formulation
US10350159B2 (en)	2010-05-31	2019-07-16	Laboratories Farmacéuticos Rovi, S.A.	Paliperidone implant formulation
US10881605B2 (en)	2010-05-31	2021-01-05	Laboratorios Farmaceuticos Rovi, S.A.	Methods for the preparation of injectable depot compositions
LT2394664T (lt)	2010-05-31	2016-09-26	Laboratorios Farmaceuticos Rovi, S.A.	Antipsichozinė injekcinė depozitinė kompozicija
HRP20211853T1 (hr)	2010-05-31	2022-03-04	Laboratorios Farmaceuticos Rovi, S.A.	Sastavi in situ injekcijskih biorazgradivih implantata
US10463607B2 (en)	2010-05-31	2019-11-05	Laboratorios Farmaceutics Rofi S.A.	Antipsychotic Injectable Depot Composition
GB2513267B (en)	2010-06-08	2015-03-18	Rb Pharmaceuticals Ltd	Injectable flowable composition comprising buprenorphine
GB2481017B (en)	2010-06-08	2015-01-07	Rb Pharmaceuticals Ltd	Microparticle buprenorphine suspension
US9272044B2 (en)	2010-06-08	2016-03-01	Indivior Uk Limited	Injectable flowable composition buprenorphine
CN103421172B (zh) *	2012-05-23	2016-01-20	上海现代药物制剂工程研究中心有限公司	一种生物可降解聚酯的纯化工艺
US20140308352A1 (en)	2013-03-11	2014-10-16	Zogenix Inc.	Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
BR112015022023B1 (pt)	2013-03-11	2022-12-06	Durect Corporation	Composição de liberação controlada injetável compreendendo transportador líquido de alta viscosidade
WO2014168134A1 (ja)	2013-04-11	2014-10-16	三井化学株式会社	乳酸―グリコール酸共重合体の製造法またはその塩の製造法
EP3861982A3 (en) *	2013-12-06	2021-09-01	Allergan, Inc.	Intracameral implant for treatment of an ocular condition
GB201404139D0 (en)	2014-03-10	2014-04-23	Rb Pharmaceuticals Ltd	Sustained release buprenorphine solution formulations
US20160106804A1 (en) *	2014-10-15	2016-04-21	Yuhua Li	Pharmaceutical composition with improved stability
US20160128997A1 (en)	2014-11-07	2016-05-12	Indivior Uk Limited	Sustained-release buprenorphine formulations
WO2017062770A1 (en)	2015-10-08	2017-04-13	Silverberg Noah	Punctal plug and bioadhesives
US10646484B2 (en)	2017-06-16	2020-05-12	Indivior Uk Limited	Methods to treat opioid use disorder
CN112545995B (zh) *	2018-05-16	2024-02-23	珠海市丽珠微球科技有限公司	一种阿立哌唑缓释微球及其制备方法
DK3861985T3 (da)	2020-02-06	2023-07-24	Ocular Therapeutix Inc	Sammensætninger og fremgangsmåder til behandling af øjensygdomme
CA3197318A1 (en)	2020-09-30	2022-04-07	Tolmar International Limited	Biodegradable polymer delivery system for extended delivery of testosterone
WO2024168022A2 (en)	2023-02-10	2024-08-15	Tolmar, Inc.	Degarelix polymeric formulations

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2551756B2 (ja)	1985-05-07	1996-11-06	武田薬品工業株式会社	ポリオキシカルボン酸エステルおよびその製造法
DE3641692A1 (de)	1986-12-06	1988-06-09	Boehringer Ingelheim Kg	Katalysatorfreie resorbierbare homopolymere und copolymere
DE3708916A1 (de)	1987-03-19	1988-09-29	Boehringer Ingelheim Kg	Verfahren zur reinigung resorbierbarer polyester
US5702716A (en)	1988-10-03	1997-12-30	Atrix Laboratories, Inc.	Polymeric compositions useful as controlled release implants
US4938763B1 (en)	1988-10-03	1995-07-04	Atrix Lab Inc	Biodegradable in-situ forming implants and method of producing the same
US5487897A (en)	1989-07-24	1996-01-30	Atrix Laboratories, Inc.	Biodegradable implant precursor
US5324519A (en)	1989-07-24	1994-06-28	Atrix Laboratories, Inc.	Biodegradable polymer composition
DE69129770T2 (de)	1990-04-13	1998-11-19	Takeda Chemical Industries Ltd	Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung
USRE37950E1 (en)	1990-04-24	2002-12-31	Atrix Laboratories	Biogradable in-situ forming implants and methods of producing the same
US6353030B1 (en) *	1990-08-01	2002-03-05	Novartis Ag	Relating to organic compounds
AU2605592A (en)	1991-10-15	1993-04-22	Atrix Laboratories, Inc.	Polymeric compositions useful as controlled release implants
EP0560014A1 (en)	1992-03-12	1993-09-15	Atrix Laboratories, Inc.	Biodegradable film dressing and method for its formation
US5681873A (en)	1993-10-14	1997-10-28	Atrix Laboratories, Inc.	Biodegradable polymeric composition
ES2171186T3 (es)	1994-04-08	2002-09-01	Atrix Lab Inc	Composiciones liquidas de difusion.
CA2214889C (en)	1995-03-10	2005-05-24	Hans Koll	Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof
US5736152A (en)	1995-10-27	1998-04-07	Atrix Laboratories, Inc.	Non-polymeric sustained release delivery system
JP4317599B2 (ja) *	1996-06-26	2009-08-19	武田薬品工業株式会社	徐放性製剤
US6264970B1 (en)	1996-06-26	2001-07-24	Takeda Chemical Industries, Ltd.	Sustained-release preparation
KR20010030891A (ko)	1997-10-03	2001-04-16	마크로메드 인코퍼레이션	가역적 열 겔화 성질을 갖는 생분해성 저분자량 트리블럭폴리(락티드-코-글리콜리드) 폴리에틸렌 글리콜 공중합체
US6261583B1 (en)	1998-07-28	2001-07-17	Atrix Laboratories, Inc.	Moldable solid delivery system
US6565874B1 (en)	1998-10-28	2003-05-20	Atrix Laboratories	Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en)	1998-10-28	2000-11-07	Atrix Laboratories, Inc.	Controlled release liquid delivery compositions with low initial drug burst
US6355657B1 (en)	1998-12-30	2002-03-12	Atrix Laboratories, Inc.	System for percutaneous delivery of opioid analgesics
US6461631B1 (en)	1999-11-16	2002-10-08	Atrix Laboratories, Inc.	Biodegradable polymer composition
AU2001276733A1 (en) *	2000-08-07	2002-02-18	Takeda Chemical Industries Ltd.	Lactic acid polymer and process for producing the same
TWI225416B (en)	2001-06-29	2004-12-21	Takeda Chemical Industries Ltd	Sustained-release composition and process for producing the same
JP5188670B2 (ja) *	2001-06-29	2013-04-24	武田薬品工業株式会社	徐放性組成物およびその製造法
US20060034889A1 (en) *	2004-08-16	2006-02-16	Macromed, Inc.	Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
JP2008520547A (ja) *	2004-10-04	2008-06-19	キューエルティーユーエスエー，インコーポレイテッド．	眼部送達のためのポリマー送達処方
PL1824460T3 (pl) *	2004-11-10	2015-09-30	Tolmar Therapeutics Inc	Stabilizowany polimerowy układ dostarczania
JP5647788B2 (ja) *	2006-10-11	2015-01-07	トルマーセラピューティクス，インコーポレイテッド．	超臨界流体抽出による低バースト特性の生分解性ポリエステルの調製
PL3660073T3 (pl)	2007-02-15	2023-12-27	Tolmar International Limited	Poli(laktyd-ko-glikolid) o niskim nagłym uwalnianiu

2008
- 2008-02-13 PL PL19203071.6T patent/PL3660073T3/pl unknown
- 2008-02-13 EP EP15185218.3A patent/EP3202814B1/en active Active
- 2008-02-13 FI FIEP19203071.6T patent/FI3660073T3/fi active
- 2008-02-13 SI SI200832213T patent/SI3660073T1/sl unknown
- 2008-02-13 HU HUE15185218A patent/HUE047775T2/hu unknown
- 2008-02-13 ES ES08725511.3T patent/ES2550014T3/es active Active
- 2008-02-13 DK DK15185218T patent/DK3202814T3/da active
- 2008-02-13 JP JP2009550095A patent/JP5342459B2/ja active Active
- 2008-02-13 HU HUE08725511A patent/HUE025842T2/en unknown
- 2008-02-13 LT LTEP19203071.6T patent/LT3660073T/lt unknown
- 2008-02-13 EP EP08725511.3A patent/EP2115029B1/en active Active
- 2008-02-13 SI SI200832098T patent/SI3202814T1/sl unknown
- 2008-02-13 PT PT192030716T patent/PT3660073T/pt unknown
- 2008-02-13 PT PT151852183T patent/PT3202814T/pt unknown
- 2008-02-13 DK DK08725511.3T patent/DK2115029T3/en active
- 2008-02-13 SI SI200831512T patent/SI2115029T1/sl unknown
- 2008-02-13 CA CA2678350A patent/CA2678350C/en not_active Expired - Fee Related
- 2008-02-13 ES ES19203071T patent/ES2956244T3/es active Active
- 2008-02-13 PL PL08725511T patent/PL2115029T3/pl unknown
- 2008-02-13 HU HUE19203071A patent/HUE063170T2/hu unknown
- 2008-02-13 PT PT87255113T patent/PT2115029E/pt unknown
- 2008-02-13 PL PL15185218T patent/PL3202814T3/pl unknown
- 2008-02-13 US US12/527,377 patent/US9187593B2/en not_active Expired - Fee Related
- 2008-02-13 LT LT15185218T patent/LT3202814T/lt unknown
- 2008-02-13 HR HRP20231117TT patent/HRP20231117T3/hr unknown
- 2008-02-13 WO PCT/US2008/001887 patent/WO2008100532A1/en active Application Filing
- 2008-02-13 EP EP19203071.6A patent/EP3660073B1/en active Active
- 2008-02-13 DK DK19203071.6T patent/DK3660073T3/da active
- 2008-02-13 ES ES15185218T patent/ES2755374T3/es active Active
2010
- 2010-05-10 HK HK10104526.3A patent/HK1138303A1/xx unknown
2013
- 2013-08-09 JP JP2013166807A patent/JP5848290B2/ja active Active
2015
- 2015-04-10 JP JP2015080726A patent/JP6195587B2/ja active Active
- 2015-09-21 HR HRP20150997TT patent/HRP20150997T1/hr unknown
- 2015-10-08 CY CY20151100906T patent/CY1116785T1/el unknown
- 2015-10-27 US US14/924,243 patent/US9561282B2/en active Active
2016
- 2016-12-19 US US15/384,117 patent/US9655970B2/en active Active
2017
- 2017-04-18 US US15/490,615 patent/US9974824B2/en active Active
2018
- 2018-04-10 US US15/950,024 patent/US10206970B2/en active Active
2019
- 2019-01-08 US US16/242,316 patent/US11147880B2/en active Active
- 2019-11-14 HR HRP20192055TT patent/HRP20192055T1/hr unknown
- 2019-11-18 CY CY20191101209T patent/CY1122304T1/el unknown
2021
- 2021-09-16 US US17/477,361 patent/US11717572B2/en active Active

Also Published As

Publication number	Publication date
ES2755374T3 (es)	2020-04-22
US20100292195A1 (en)	2010-11-18
EP3202814A1 (en)	2017-08-09
PT3660073T (pt)	2023-08-31
US10206970B2 (en)	2019-02-19
PT3202814T (pt)	2019-11-26
HUE025842T2 (en)	2016-04-28
WO2008100532A1 (en)	2008-08-21
HK1138303A1 (en)	2010-08-20
CY1122304T1 (el)	2021-01-27
JP2010519218A (ja)	2010-06-03
JP6195587B2 (ja)	2017-09-13
EP2115029B1 (en)	2015-09-16
US9561282B2 (en)	2017-02-07
CA2678350C (en)	2015-11-17
JP2013224339A (ja)	2013-10-31
ES2550014T3 (es)	2015-11-03
US20170216395A1 (en)	2017-08-03
ES2956244T3 (es)	2023-12-15
PL3202814T3 (pl)	2020-01-31
US20160106847A1 (en)	2016-04-21
US11147880B2 (en)	2021-10-19
HUE063170T2 (hu)	2024-01-28
EP3660073B1 (en)	2023-07-12
CA2678350A1 (en)	2008-08-21
US9187593B2 (en)	2015-11-17
EP3202814B1 (en)	2019-10-16
DK3202814T3 (da)	2019-11-25
FI3660073T3 (fi)	2023-09-11
US20180311305A1 (en)	2018-11-01
US20190209643A1 (en)	2019-07-11
SI3202814T1 (sl)	2019-12-31
US20170095560A1 (en)	2017-04-06
SI2115029T1 (sl)	2016-01-29
EP3660073A1 (en)	2020-06-03
JP2015127351A (ja)	2015-07-09
US9655970B2 (en)	2017-05-23
PL2115029T3 (pl)	2016-01-29
HRP20192055T1 (hr)	2020-02-21
HUE047775T2 (hu)	2020-05-28
DK2115029T3 (en)	2015-10-05
HRP20150997T1 (hr)	2015-12-18
EP2115029A1 (en)	2009-11-11
PL3660073T3 (pl)	2023-12-27
JP5848290B2 (ja)	2016-01-27
PT2115029E (pt)	2015-10-26
US20220202941A1 (en)	2022-06-30
HRP20231117T3 (hr)	2023-12-22
JP5342459B2 (ja)	2013-11-13
CY1116785T1 (el)	2017-03-15
US9974824B2 (en)	2018-05-22
US11717572B2 (en)	2023-08-08
DK3660073T3 (da)	2023-09-18
LT3202814T (lt)	2019-12-10
SI3660073T1 (sl)	2023-10-30

Publication	Publication Date	Title
HUE063170T2 (hu)	2024-01-28	Alacsony kitörési tulajdonságú poli(laktid-ko-glikolid)
ZA200808637B (en)	2009-12-30	Polymers
IL185609A0 (en)	2008-01-06	Multi function senssor
AP2010005314A0 (en)	2010-08-31	Nanodispersian
GB0820231D0 (en)	2008-12-10	Airbagmodul, airbagmodulanordung und befestigungsverfahren
GB0719064D0 (en)	2007-11-07	simple steps
GB0604911D0 (en)	2006-04-19	Polymers
IL200613A0 (en)	2010-05-17	Erythromycin-based macrolides
TWI347625B (en)	2011-08-21	Wireless switch module
HK1126892A1 (en)	2009-09-11	Wireless switch module
GB0720530D0 (en)	2007-11-28	Readers
EP2026825A4 (en)	2012-07-04	FURANON-INITIATED POLYMERS
EP2134587A4 (en)	2013-09-18	INTERMEDIATE TRACTION BAR ARRANGEMENT
GB0617450D0 (en)	2006-10-18	Liverstock carriers
GB0724985D0 (en)	2008-01-30	Molecular KNEX-structures
GB0718456D0 (en)	2007-10-31	Molecular knex-structures
GB0701036D0 (en)	2007-02-28	.
GB0701035D0 (en)	2007-02-28	.
GB0722633D0 (en)	2007-12-27	Flipper
IL181852A0 (en)	2007-07-04	D.s-hom
GB0702065D0 (en)	2007-03-14	Just one more two
GB0709794D0 (en)	2007-06-27	Step
IL182708A0 (en)	2008-03-20	Silivirax porta
GB0707456D0 (en)	2007-05-23	Tolerance
GB0713326D0 (en)	2007-08-22	Richochet (Hexachart)